Alcohol Dependence: Neurobiology, Consequences, and Treatment

Alcohol use disorder (AUD) is a chronic brain disease characterized by impaired control, social impairment, risky use, and pharmacological criteria (tolerance, withdrawal).

Neurobiology

  • Reward pathway: Alcohol → ↑ dopamine in nucleus accumbens → reinforcement.
  • GABAergic: Potentiates GABA-A → sedation, anxiolysis.
  • Glutamatergic: Inhibits NMDA → cognitive impairment; chronic use → upregulation → hyperexcitability on withdrawal.
  • Prefrontal cortex: Atrophy → impaired executive function, decision-making, impulse control.

Withdrawal Syndrome

6–24 h post-last drink: anxiety, tremor, tachycardia, nausea. 24–72 h: seizures, hallucinations. 72 h+: delirium tremens (DTs) – mortality 5–15% untreated. Medical detox (benzodiazepines) essential for moderate-severe AUD.

Treatment

  • Medications: Naltrexone (craving), acamprosate (abstinence), disulfiram (aversion), topiramate/gabapentin (off-label).
  • Psychotherapy: CBT, MET, contingency management, 12-step facilitation.
  • Mutual aid: AA, SMART Recovery, LifeRing.
  • Levels of care: Outpatient → IOP → residential → medically managed inpatient.

Recovery is non-linear; relapse is common but not failure. Long-term remission achievable.

Drug Addiction - Related Articles